An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of Differentiation Antigen 19/20(CD19/CD20) Dual Specific CAR-T Cells Injection
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of ICP-022 in Patients With R/R DLBCL
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
- Status
- COMPLETED
- Phase
- N/A
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
- Status
- COMPLETED
- Phase
- N/A
A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- RECRUITING
- Phase
- N/A
Diet, Physical Activity and Body Composition Changes During R-CHOP
- Status
- WITHDRAWN
- Phase
- N/A
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2